About JC Medical

Help doctors treat illnesses and save people

[Academic Reprint] Largest sample size! Huaxi Hospital Team Publishes Research Results on TAVR for Aortic Valve Regurgitation

  • 2021-05-07

(Summary description)Aortic regurgitation encompasses a complex array of pathophysiologic mechanisms. According to the literature, the percentage of the general population with severe aortic regurgitation is approximately 1%. The average life expectancy of this group is only about 5 years from the time of diagnosis of the disease. As of today, surgical aortic valve replacement (SAVR) remains the mainstay of treatment for severe aortic regurgitation, while patients at very high risk for surgical procedures or with significant contraindications are usually treated conservatively.

[Academic Reprint] Largest sample size! Huaxi Hospital Team Publishes Research Results on TAVR for Aortic Valve Regurgitation

(Summary description)Aortic regurgitation encompasses a complex array of pathophysiologic mechanisms. According to the literature, the percentage of the general population with severe aortic regurgitation is approximately 1%. The average life expectancy of this group is only about 5 years from the time of diagnosis of the disease. As of today, surgical aortic valve replacement (SAVR) remains the mainstay of treatment for severe aortic regurgitation, while patients at very high risk for surgical procedures or with significant contraindications are usually treated conservatively.

  • Categories:Home Scroll
  • Author:中华医学会胸心分会
  • Origin:https://mp.weixin.qq.com/s/YsSuHruGvSQTg2KKG14Ttg
  • Time of issue:2021-05-07 15:06
  • Views:
 JC Medical

 About Us

 

 

>  JC Medical Academy

 

 

>  Product Introduction

Contact details

 

+86-512-63036188

Address: C21 Building, 218 Xinghu Street, Suzhou Industrial Park

E-mail:info@jiechengmedical.com

 JC Medical

Follow Jiecheng Medical

 JC Medical

Follow Genesis 

MedTech